DOI: 10.1055/s-00000133

Gastroenterologie up2date

References

Yao JC, Fazio N, Singh S. et al.
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study.

Lancet 2016;
387: 968-977
doi:10.1016/S0140-6736(15)00817-X

Download Bibliographical Data

Access:
Access:
Access: